The historical rank and industry rank for Niagen Bioscience's Net Margin % or its related term are showing as below:
NAGE'
s Net Margin % Range Over the Past 10 Years
Min: -105.57 Med: -28.29 Max: 8.59
Current: 8.59
NAGE's Net Margin % is ranked better than 80.74% of 1002
companies
in the Biotechnology industry
Industry Median: -132.42
vs NAGE: 8.59
Niagen Bioscience Net Margin % Historical Data
The historical data trend for Niagen Bioscience's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Niagen Bioscience's Net Margin %
For the Biotechnology subindustry, Niagen Bioscience's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Niagen Bioscience's Net Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Niagen Bioscience's Net Margin % distribution charts can be found below:
* The bar in red indicates where Niagen Bioscience's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Niagen Bioscience (NAS:NAGE) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Niagen Bioscience Net Margin % Related Terms
Thank you for viewing the detailed overview of Niagen Bioscience's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NAGE has been successfully added to your 